PHARMAIDS PHARMACEUTICALS LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 0.21 | NA | NA | NA |
Total Expenditure | 13.16 | 10.21 | 16.07 | 86.02 |
PBIDT (Excl OI) | -12.95 | -10.21 | -16.07 | -86.02 |
Other Income | -9.01 | -2.58 | 3.72 | NA |
Operating Profit | -21.96 | -12.79 | -12.35 | -86.02 |
Interest | NA | 0.00 | 0.01 | 0.02 |
Exceptional Items | NA | NA | NA | NA |
PBDT | -21.96 | -12.79 | -12.36 | -86.04 |
Depreciation | 0.14 | 0.09 | 0.08 | 0.01 |
Profit Before Tax | -22.1 | -12.88 | -12.44 | -86.05 |
Tax | -5.76 | -7.83 | 0.94 | -24.43 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | -16.34 | -5.05 | -13.38 | -61.62 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | -16.34 | -5.05 | -13.38 | -61.62 |
Minority Interest | NA | NA | NA | NA |
Shares of Associates | 0.38 | |||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | -16.34 | -5.04 | -13 | -61.62 |
Equity Capital | 214.44 | 214.44 | 214.86 | 214.44 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | NA | NA | NA | NA |
Calculated EPS | -0.76 | -0.23 | -0.60 | -2.87 |
Calculated EPS (Annualised) | -3.04 | -0.94 | -2.42 | -11.49 |
No of Public Share Holdings | 19497830 | 19402475 | 19350708 | 19347523 |
% of Public Share Holdings | 90.75 | 90.3 | 90.06 | 90.05 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | -6166.66 | NA | NA | NA |
PBIDTM% | -10457.14 | NA | NA | NA |
PBDTM% | -10457.14 | NA | NA | NA |
PBTM% | -10523.80 | NA | NA | NA |
PATM% | -7780.95 | NA | NA | NA |
"; | Notes | Notes | Notes | Notes |